Healthcare ServicesCompany
Who owns Novozymes Biopharma Sweden AB?
Novozymes Biopharma Sweden AB is owned by Repligen. It was acquired in 2011.
Novozymes Biopharma Sweden AB is owned by Repligen. It was acquired in 2011.
St. Lars Vag 47,
Lund,
220 95
Sweden,
| Status | Dates | Investor(s) | |
|---|---|---|---|
| Investment | Exit | ||
| Current | 2011-10-27 | Repligen | |
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.